UK markets closed

Edgewise Therapeutics, Inc. (EWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.09+0.75 (+3.69%)
As of 02:36PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
90,905
90,905
54,032
32,189
14,983
Selling general and administrative
23,452
23,452
17,626
11,026
2,209
Total operating expenses
114,357
114,357
71,658
43,215
17,192
Operating income or loss
-114,357
-114,357
-71,658
-43,215
-17,192
Income before tax
-100,163
-100,163
-67,640
-42,813
-17,123
Income from continuing operations
-100,163
-100,163
-67,640
-42,813
-17,123
Net income
-100,163
-100,163
-67,640
-42,813
-17,123
Net income available to common shareholders
-100,163
-100,163
-67,640
-42,813
-17,123
Basic EPS
-1.40
-
-1.26
-1.14
-0.37
Diluted EPS
-1.40
-
-1.26
-1.14
-0.37
Basic average shares
63,361
-
53,594
37,526
46,567
Diluted average shares
63,361
-
53,594
37,526
46,567